Photo from wikipedia
Veno-venous extracorporeal membrane oxygenation (VV-ECMO) has become a mainstay treatment modality for a select patient population who do not respond to conventional medical therapy suffering from severe COVID-19 acute respiratory… Click to show full abstract
Veno-venous extracorporeal membrane oxygenation (VV-ECMO) has become a mainstay treatment modality for a select patient population who do not respond to conventional medical therapy suffering from severe COVID-19 acute respiratory distress syndrome (ARDS). This therapy necessitates the utilization of anticoagulation, whether unfractionated heparin or bivalirudin, to prevent thrombotic complications. Scarce are reports of VV-ECMO implementation leading to acute hemorrhage mandating cessation of anticoagulation in a patient suffering from COVID-19 ARDS. Herein, we report a case of a successful outcome in a COVID-19 ARDS patient who suffered an acute hemorrhagic complication leading to pre-emptive termination of systemic anticoagulation. We believe this to be one of the first such cases in the literature.
Journal Title: Journal of Cardiothoracic and Vascular Anesthesia
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!